@pandica.com
Surgery/oncology
Pandica LTD
Early identification of high-risk pancreatic cystic neoplasms (PCNs) is critical for prevention of pancreatic ductal adenocarcinoma, yet current diagnostic tools remain limited in sensitivity and specificity. We developed a physiologic and minimally invasive method—Duodenal Aspiration Liquid Biopsy (DALB)—to obtain pancreaticobiliary secretions for cytological and biochemical analysis prior to endoscopic ultrasound (EUS) or biopsy. This study aimed to assess the clinical utility of DALB for early risk stratification in patients with PCNs. Between 2023 and 2025, we prospectively enrolled 35 patients with PCNs detected on MRI or CT. Before performing EUS or other invasive procedures, we used the Pandicath system to isolate the duodenal segment surrounding the major papilla and collect a physiologically stimulated secretion sample after oral liquid intake. The aspirate was analyzed for carcinoembryonic antigen (CEA) and cytological abnormalities.
Scopus Publications